HSN Shares Hansen Technologies Limited
ASX · ASXLast in our picks 2026-10-19 — not in the current list; analysis below is from that screen
Recurring healthcare software exposure and stable contracted revenue support dependable compounding.
Future value: $5.70 (+65.70%) · 6-12 months
Signal breakdown
- ▸Recurring software revenue and healthcare technology exposure.
- ▾Below 50-day MA (-0.1%)
- ▸~66% upside to price target
Is HSN a buy right now?
Trend: HSN is trading above the 50-day average (+9.88%), RSI 57 — neutral momentum, with a 3-month return of -13.24%.
Valuation & quality: Hansen Technologies Limited trades on a trailing P/E of 16.0, forward P/E 12.5, price-to-book 1.95; fundamentals show net margin 12.4%, return on equity 12.5%, revenue growth -8.9% year on year.
Analyst consensus: 9 analysts have a mean 12-month price target of A$5.40 (+47% vs the last close; range A$3.20 – A$6.80), consensus rating “none”.
Income: trailing dividend yield 2.75%.
Our screen: ACCUMULATE (score 1) — Recurring healthcare software exposure and stable contracted revenue support dependable compounding.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -6.20% | +1.00% | -7.60% | -4.30% | -4.70% | -19.10% | -9.40% | +18.40% |
Fundamentals
Analyst price target
Technical signals
About Hansen Technologies Limited
Hansen Technologies Limited engages in the development, implementation, and support of billing and customer information systems. The company operates through Energy & Utilities, and Communications & Media segment.
Sector: Technology · Industry: Software - Application · Australia · 1,493 employees · Website
Related Health Care picks
Browse: all ASX stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.